These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31483085)
1. Identification of potential drug name confusion errors in the Sentinel System. Cocoros NM; Haynes K; Her Q; Cosgrove A; Dee E; Lin ND; Tu CM; Ding Y; Nguyen M; Toh S Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1405-1410. PubMed ID: 31483085 [TBL] [Abstract][Full Text] [Related]
2. Clinical Psychopharmacology Update: What's in a Name? Confusion Prompts Change for Vortioxetine's Brand Name. Tobin TJ; Tobin ML Issues Ment Health Nurs; 2016 Sep; 37(9):695-697. PubMed ID: 27387386 [TBL] [Abstract][Full Text] [Related]
3. Prevention strategies to identify LASA errors: building and sustaining a culture of patient safety. Lizano-Díez I; Figueiredo-Escribá C; Piñero-López MÁ; Lastra CF; Mariño EL; Modamio P BMC Health Serv Res; 2020 Jan; 20(1):63. PubMed ID: 31996197 [TBL] [Abstract][Full Text] [Related]
4. Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary. Roman MW; Wilkinson SM Issues Ment Health Nurs; 2014 Dec; 35(12):972-4. PubMed ID: 25426751 [TBL] [Abstract][Full Text] [Related]
5. Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data. Hoffman V; Xue F; Gardstein B; Skerry K; Critchlow CW; Enger C Osteoporos Int; 2016 Apr; 27(4):1653-1658. PubMed ID: 26558380 [TBL] [Abstract][Full Text] [Related]
6. Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools. Sobel RE; Bate A; Marshall J; Haynes K; Selvam N; Nair V; Daniel G; Brown JS; Reynolds RF Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):332-339. PubMed ID: 29392851 [TBL] [Abstract][Full Text] [Related]
7. Development of an algorithm to detect methotrexate wrong frequency error using computerized health care data. Herrinton LJ; Woodworth TS; Eworuke E; Amsden LB; Liu L; Wyeth J; Petrone A; Menzin TJ; Williams J; Goldfien R; Nguyen M Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1361-1368. PubMed ID: 31410932 [TBL] [Abstract][Full Text] [Related]
8. Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study. Lambert BL; Schroeder SR; Galanter WL BMJ Qual Saf; 2016 Apr; 25(4):213-7. PubMed ID: 26700541 [No Abstract] [Full Text] [Related]
10. [Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery]. Zyryanov SK; Belousov DY; Afanasyeva EV; Dumchenko EV Ter Arkh; 2016; 88(9):39-49. PubMed ID: 27735912 [TBL] [Abstract][Full Text] [Related]
11. Association between licence status and medication errors. Conroy S Arch Dis Child; 2011 Mar; 96(3):305-6. PubMed ID: 21131639 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome. Spoendlin J; Gagne JJ; Lewey JJ; Patorno E; Schneeweiss S; Desai RJ Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1361-1370. PubMed ID: 30379372 [TBL] [Abstract][Full Text] [Related]
13. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586 [TBL] [Abstract][Full Text] [Related]
14. Congress investigates FDA's handling of antidepressant safety information. Young D Am J Health Syst Pharm; 2004 Nov; 61(21):2228, 2230, 2232 passim. PubMed ID: 15552624 [No Abstract] [Full Text] [Related]
15. Reducing medication errors through naming, labeling, and packaging. Berman A J Med Syst; 2004 Feb; 28(1):9-29. PubMed ID: 15171066 [TBL] [Abstract][Full Text] [Related]
16. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380 [No Abstract] [Full Text] [Related]
17. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence. Czaja AS; Valuck R Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):997-1004. PubMed ID: 22760843 [TBL] [Abstract][Full Text] [Related]
18. Ascertaining vaccine exposure at the brand level using real-world data. Lasky T Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):763-765. PubMed ID: 30916840 [No Abstract] [Full Text] [Related]
19. Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database. Blin P; Dureau-Pournin C; Benichou J; Bonello L; Dallongeville J; Danchin N; Falissard B; Thomas-Delecourt F; Jové J; Lassalle R; Droz C; Moore N Atherosclerosis; 2019 Feb; 281():98-106. PubMed ID: 30658197 [TBL] [Abstract][Full Text] [Related]
20. Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials. Shepshelovich D; Tibau A; Goldvaser H; Molto C; Ocana A; Seruga B; Amir E J Clin Oncol; 2018 Jun; 36(18):1798-1804. PubMed ID: 29641296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]